Abstract: A method, NodeB and User Equipment for TDD operation in a communication system operating in TDD mode in a frequency band allocated for FDD operation. Preferably, operation is in TDD uplink and downlink mode in a first frequency band designated or normally used for FDD uplink communication, and in TDD downlink-only mode in a second frequency band designated or normally used for FDD downlink communication. The invention provides the following advantages: Provides a flexible method to deploy a time division duplex architecture in frequency division duplex spectrum. Allows flexible use of system capacity by adjusting the uplink and downlink capacity split. Removes previous FDD duplex restrictions.

Abstract: A method, NodeB and User Equipment for TDD operation in a communication system operating in TDD mode in a frequency band allocated for FDD operation. Preferably, operation is in TDD uplink and downlink mode in a first frequency band designated or normally used for FDD uplink communication, and in TDD downlink-only mode in a second frequency band designated or normally used for FDD downlink communication. The invention provides the following advantages: Provides a flexible method to deploy a time division duplex architecture in frequency division duplex spectrum. Allows flexible use of system capacity by adjusting the uplink and downlink capacity split. Removes previous FDD duplex restrictions.

Abstract: Described herein are a thermo-electric generator module and a method for constructing the thermo-electric generator module. The thermo-electric generator module includes a plurality of thermo-electric plates on a surface of a heat absorption member; and a heat dissipation region that encases the heat absorption member. The thermo-electric module is connected in series with other thermo-electric generator modules to facilitate generation of electricity.

Abstract: The present invention relates to compositions of submicron- to micron-size particles of antimicrobial agents. More particularly the invention relates to a composition of an antimicrobial agent that renders the agent potent against organisms normally considered to be resistant to the agent. The composition comprises an aqueous suspension of submicron- to micron-size particles containing the agent coated with at least one surfactant selected from the group consisting of: ionic surfactants, non-ionic surfactants, biologically derived surfactants, and amino acids and their derivatives. The particles have a volume-weighted mean particle size of less than 5 ?m as measured by laser diffractometry.

Abstract: Stable pharmaceutical formulations and methods of making same are provided. In a general embodiment, the present disclosure provides a method of making a stable pharmaceutical formulation comprising adding one or more vitrifying additives to an aqueous pharmaceutical solution to raise the glass transition temperature of the aqueous pharmaceutical solution. The aqueous pharmaceutical solution can be cooled to a temperature of about ?50° C. to about ?10° C. The vitrifying additive enhances the formation of a glass or amorphous solid of the aqueous pharmaceutical solution at cryogenic temperatures (?50 to ?10° C.), and the pharmaceutical formulation can be thawed to liquid form and administered to a mammalian subject.

Abstract: Stable pharmaceutical formulations and methods of making same are provided. In a general embodiment, the present disclosure provides a method of making a stable pharmaceutical formulation comprising adding one or more vitrifying additives to an aqueous pharmaceutical solution to raise the glass transition temperature of the aqueous pharmaceutical solution. The aqueous pharmaceutical solution can be cooled to a temperature of about ?50° C. to about ?10° C. The vitrifying additive enhances the formation of a glass or amorphous solid of the aqueous pharmaceutical solution at cryogenic temperatures (?50 to ?10° C.), and the pharmaceutical formulation can be thawed to liquid form and administered to a mammalian subject.

Abstract: A method, NodeB (320) and User Equipment (330) for TDD operation in a communication system operating in TDD mode in a frequency band allocated for FDD operation. Preferably, operation is in TDD uplink and downlink mode in a first frequency band designated or normally used for FDD uplink communication, and in TDD downlink-only mode in a second frequency band designated or normally used for FDD downlink communication. The invention provides the following advantages: Provides a flexible method to deploy a time division duplex architecture in frequency division duplex spectrum. Allows flexible use of system capacity by adjusting the uplink and downlink capacity split. Removes previous FDD duplex restrictions.

Abstract: A system (10) for cleaning atmospheric pollution, the system (10) including at least ne air inlet (30) of a building (20) to draw polluted air (15) from the atmosphere, an air passageway (55) to direct the polluted air (15) to a filtration system (80) located at the premises of the building (20) to filter the polluted air (15), and at least one air outlet (81) of the building (20) to direct the filtered air (90) into the atmosphere.

Abstract: The present invention relates to compositions of submicron- to micron-size particles of antimicrobial agents. More particularly the invention relates to a composition of an antimicrobial agent that renders the agent potent against organisms normally considered to be resistant to the agent. The composition comprises an aqueous suspension of submicron- to micron-size particles containing the agent coated with at least one surfactant selected from the group consisting of: ionic surfactants, non-ionic surfactants, biologically derived surfactants, and amino acids and their derivatives. The particles have a volume-weighted mean particle size of less than 5 ?m as measured by laser diffractometry.

Abstract: Stable pharmaceutical formulations and methods of making same are provided. In a general embodiment, the present disclosure provides a method of making a stable pharmaceutical formulation comprising adding one or more vitrifying additives to an aqueous pharmaceutical solution to raise the glass transition temperature of the aqueous pharmaceutical solution. The aqueous pharmaceutical solution can be cooled to a temperature of about ?50° C. to about ?10° C. The vitrifying additive enhances the formation of a glass or amorphous solid of the aqueous pharmaceutical solution at cryogenic temperatures (?50 to ?10° C.), and the pharmaceutical formulation can be thawed to liquid form and administered to a mammalian subject.

Abstract: The disclosure describes apparatuses and methods of use that may be used to remove material with magnetic properties from compositions, particularly pharmaceutical compositions. The apparatuses provide a conduit or column in which a magnetic field exists and through which a composition flows. Magnetic material in the composition is substantially reduced after flowing through the conduit or column.

Abstract: Methods and apparatuses for comminuting and stabilizing small particles are provided. In one embodiment, an apparatus moves an organic compound dissolved in a solvent to form a suspension of particles in a first fluid stream and moves the suspension in a second fluid stream, wherein the second fluid stream is oriented and positioned with respect to the first stream to cause shearing between the streams and mixing of at least some of the particles in the first and second streams.

Abstract: A user interface for providing an information gateway between a user and a computer platform includes two or more windows for displaying information, and for facilitating information entry from a user. The windows may be in the form of a rectangular box, although other shapes may be used. The size and/or shape of each of the windows changes as the window content changes. The user interface requires the user sequentially step through the windows, completing the required data entry for each window before proceeding to the subsequent window. As the user encounters a particular window, that window expands to display details of the window content. When the user completes the data entry fields of an expanded window and proceeds to the subsequent window, the completed window collapses to display a summary of the content. The expansion or collapse of a window may occur in a gradual or abrupt transition.

Abstract: The present invention provides a polymorphic form of itraconazole.

Abstract: The present invention provides a method for determining a particle size.

Abstract: The present invention provides a method for preparing submicron sized particles of an organic compound, the solubility of which is greater in a water-miscible first solvent than in a second solvent which is aqueous, the process including the steps of: (i) dissolving the organic compound in the water-miscible first solvent to form a solution, (ii) mixing the solution with the second solvent to define a pre-suspension; and (iii) adding energy to the pre-suspension to form particles having an average effective particle size of 400 nm to 2 microns.

Abstract: The present invention provides for measuring a particle size distribution of a population of particles using a light scattering particle sizing instrument having a plurality of selectable imaginary component values of the refractive index. The particles each having a particle size and the process includes the steps of: (i) providing a population of the particles, wherein the particles have a refractive index; (ii) determining a real component of the refractive index of the particles using the Becke Line Method; (iii) determining an imaginary component of the refractive index of the particles; and (iv) determining the particle size distribution of the particles by the light scattering particle sizing instrument wherein the particle size distribution is determined using the real component of the refractive index measured in step (ii) and the imaginary component of the refractive index determined in step (iii).

Abstract: A deep fryer has an outer housing (4) closed by a lid (14) and an immersed type heating element (28) extending into an oil containing receptacle (22), the housing having an upper rim at which the lid (14) is supported, with the underside of the lid (14) having an upwardly domed shape and the rim formed with a channel (44) arranged beneath the periphery of the underside of lid (14) to receive droplets of moisture condensing on the underside of the lid during use, a sensor (31) being provided which includes a thermal use and temperature sensing element (56) disposed in a single tubular housing.

Abstract: The present invention provides a method for preparing submicron sized particles of an organic compound, the solubility of which is greater in a water-miscible first solvent than in a second solvent which is aqueous, the process including the steps of: (i) dissolving the organic compound in the water-miscible first solvent to form a solution, (ii) mixing the solution with the second solvent to define a pre-suspension; and (iii) adding energy to the pre-suspension to form particles having an average effective particle size of less than about 2 ?m.

Abstract: The present invention provides a method for preparing a suspension of a pharmaceutically-active compound, the solubility of which is greater in a water-miscible first organic solvent than in a second solvent which is aqueous. The process includes the steps of: (i) dissolving a first quantity of the pharmaceutically-active compound in the water-miscible first organic solvent to form a first solution; (ii) mixing the first solution with the second solvent to precipitate the pharmaceutically-active compound; and (iii) seeding the first solution or the second solvent or the pre-suspension.